Experimental Drug Could Rein in Epilepsy Seizures
TUESDAY, Oct. 10, 2023 (HealthDay News) — For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them.Dubbed XEN1101, the new drug reduced…
Learn MoreLa terapia con células madre podría ser un avance contra la diabetes tipo 1
MIÉRCOLES, 4 de octubre de 2023 (HealthDay News) — Las personas con diabetes tipo 1 carecen de células funcionales de los islotes en su páncreas para producir la hormona insulina y deben recibirla diariamente a través de inyecciones o una bomba conti…
Learn MoreKetamine Nasal Spray Shows Promise Against Tough-to-Treat Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found.The trial, of nearly 700 people with…
Learn MoreDiversity in Early-Phase Cancer Trials Improved Since 2000
TUESDAY, Oct. 3, 2023 (HealthDay News) — There have been some increases in diversity in early-phase cancer clinical trials since 2000, according to a study presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Et…
Learn MoreSurvival Similar for Black, White Prostate Cancer Patients in Clinical Trial Setting
FRIDAY, Aug. 4, 2023 (HealthDay News) — For metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generation androgen receptor pathw…
Learn MoreUna inyección experimental administrada cada seis meses controló la hipertensión en un ensayo inicial
JUEVES, 20 de julio de 2023 (HealthDay News) — Cada día, millones de personas deben tomar una o más pastillas para controlar su presión arterial y reducir el riesgo de ataque cardiaco o accidente cerebrovascular (ACV), pero si una nueva investigación…
Learn MoreExperimental Shot Given Every Six Months Controlled High Blood Pressure in Early Trial
THURSDAY, July 20, 2023 (HealthDay News) — Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack or stroke, but if new research pans out, some may be able to scrap their pills…
Learn MoreUn fármaco experimental para el Alzheimer ralentiza el declive del pensamiento en un ensayo avanzado
LUNES, 17 de julio de 2023 (HealthDay News) — Parece que otro medicamento experimental que busca ralentizar el daño del Alzheimer está a punto de unirse a un creciente arsenal de nuevos tratamientos para esta enfermedad que roba la memoria. En una in…
Learn MoreExperimental Alzheimer’s Drug Slows Thinking Declines in Late-Stage Trial
MONDAY, July 17, 2023 (HealthDay News) — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease.In research published online Monday in the Journal o…
Learn More